Hamilton MJ - Search Results

1

Hamilton MJ, Odze RD. Hamilton MJ, et al. Inflamm Bowel Dis. 2017 Feb;23(2):E8-E9. doi: 10.1097/MIB.0000000000001019. Inflamm Bowel Dis. 2017. PMID: 28107280 No abstract available.

2

Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.

Burakoff R, Pabby V, Onyewadume L, Odze R, Adackapara C, Wang W, Friedman S, Hamilton M, Korzenik J, Levine J, Makrauer F, Cheng C, Smith HC, Liew CC, Chao S. Burakoff R, et al. Inflamm Bowel Dis. 2015 May;21(5):1132-40. doi: 10.1097/MIB.0000000000000340. Inflamm Bowel Dis. 2015. PMID: 25895006

3

Prospective Evaluation of Terminal Ileitis in a Surveillance Population of Patients with Ulcerative Colitis.

Hamilton MJ, Makrauer FM, Golden K, Wang H, Friedman S, Burakoff RB, Levine JS, Joshi P, Banks PA, Odze RD. Hamilton MJ, et al. Inflamm Bowel Dis. 2016 Oct;22(10):2448-55. doi: 10.1097/MIB.0000000000000911. Inflamm Bowel Dis. 2016. PMID: 27580386 Free PMC article.

4

Adenocarcinoma complicating ulcerative colitis presenting as multiple pseudopolyp-like lesions.

Hamilton MJ, Rege TA, Odze RD. Hamilton MJ, et al. Clin Gastroenterol Hepatol. 2012 Jun;10(6):xxv. doi: 10.1016/j.cgh.2011.10.040. Epub 2011 Dec 8. Clin Gastroenterol Hepatol. 2012. PMID: 22155756 No abstract available.

5

Clinical, pathologic, and outcome study of hyperplastic and sessile serrated polyps in inflammatory bowel disease.

Shen J, Gibson JA, Schulte S, Khurana H, Farraye FA, Levine J, Burakoff R, Cerda S, Qazi T, Hamilton M, Srivastava A, Odze RD. Shen J, et al. Hum Pathol. 2015 Oct;46(10):1548-56. doi: 10.1016/j.humpath.2015.06.019. Epub 2015 Jul 8. Hum Pathol. 2015. PMID: 26297256

6

Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.

Burke KE, Kochar B, Allegretti JR, Winter RW, Lochhead P, Khalili H, Colizzo FP, Hamilton MJ, Chan WW, Ananthakrishnan AN. Burke KE, et al. Among authors: hamilton mj. Inflamm Bowel Dis. 2021 Jan 19;27(2):155-161. doi: 10.1093/ibd/izaa278. Inflamm Bowel Dis. 2021. PMID: 33089863 Free PMC article.

7

Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort.

Shelton E, Allegretti JR, Stevens B, Lucci M, Khalili H, Nguyen DD, Sauk J, Giallourakis C, Garber J, Hamilton MJ, Tomczak M, Makrauer F, Burakoff RB, Levine J, de Silva P, Friedman S, Ananthakrishnan A, Korzenik JR, Yajnik V. Shelton E, et al. Among authors: hamilton mj. Inflamm Bowel Dis. 2015 Dec;21(12):2879-85. doi: 10.1097/MIB.0000000000000561. Inflamm Bowel Dis. 2015. PMID: 26288002 Free PMC article.

8

Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated.

Allegretti JR, Canakis A, McClure E, Marcus J, Norton BA, Hamilton MJ, Winter RW, De Silva PS, Friedman S, Korzenik JR. Allegretti JR, et al. Among authors: hamilton mj. Inflamm Bowel Dis. 2021 Nov 15;27(12):2031-2033. doi: 10.1093/ibd/izab131. Inflamm Bowel Dis. 2021. PMID: 34142700 No abstract available.

9

Stress in the ER leads to inflammatory bowel disease.

Hamilton MJ, Stevens RL. Hamilton MJ, et al. Inflamm Bowel Dis. 2009 Nov;15(11):1765-6. doi: 10.1002/ibd.20969. Inflamm Bowel Dis. 2009. PMID: 19408317 No abstract available.

10

The multifaceted mast cell in inflammatory bowel disease.

Hamilton MJ, Frei SM, Stevens RL. Hamilton MJ, et al. Inflamm Bowel Dis. 2014 Dec;20(12):2364-78. doi: 10.1097/MIB.0000000000000142. Inflamm Bowel Dis. 2014. PMID: 25401721 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page